Smith & Nephew supports healthcare professionals in more than 100 countries in their daily efforts to improve the lives of their patients.
We do this by taking a pioneering approach to the design of our advanced medical products and services, by securing wider access to our diverse technologies for more customers globally, and by enabling better outcomes for patients and healthcare systems.
We have leadership positions in:
We have around 16,000 employees around the world.
We are a constituent of the UK's FTSE100 and our shares are traded on the London Stock Exchange and through American Depository Receipts on the New York Stock Exchange (LSE: SN, NYSE: SNN)